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Abstract 
The interaction of the antipsychotic drug trifluoperazine (TFP) with membranes was investigated in terms of lipid phase 
perturbation. TFP partition coefficients (P) were measured by phase separation between octanol/water and model 
membranes/water. The profile of P values at pH 7.4 was: microsomes (7172+ 1229) > liposomes (1916+ 341) > eryth- 
rocyte ghosts (1380_+429)> octanol (452_+55). Hemolytic experiments howed a biphasic, protective (at lower 
concentrations) and hemolytic effect above the CMC (42 ~tM at pH 7.4) of the phenothiazine. By applying classical 
treatments for surface active compounds to the hemolytic urves, we could calculate P values in whole erythrocyte c lls. The 
preferential binding of uncharged to charged TFP in the membrane was discussed, since it results in a ionization constant 
(pKapp) different from that observed in the aqueous phase (pK). The TFP ionization constant was decreased from 8.1 (in 
water) to 7.62 in the presence of membranes and almost the same ratio of charged/uncharged TFP species is present at 
physiologic pH. Taking into account the ApK, we calculated the average TFP partition coefficient between egg 
phosphatidylcholine liposomes and water, at pH 7.4 (P ..... ge = 1432), which was well correlated with the measured one 
(plip= 1916). Paverage is highly influenced by the uncharged TFP species and the real base/acid ratio under physiologic 
conditions was discussed in terms of its possible role in the biological activity of TFP. © 1998 Elsevier Science B.V. All 
rights reserved. 
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1. Introduction 
Phenothiazines are known as neuroleptics and 
antihistaminic agents [1]. Trifluoperazine (TFP), a 
phenothiazine d rivative, is a widely used calmodulin 
antagonist and one of the most effective antipsy- 
chotic agents [2]. 
Abbreviations: CMC, critical micellar concentration; CPZ, chlorpromazine; Csat, solute concentration for the onset of hemolysis; Csol, 
solute concentration for total lysis; EPC, egg phosphatidylcholine; EPR, electron paramagnetic resonance; P, partition coefficient; PC, 
phosphatidyl choline; pK, ionization constant in water; pKapp ionization constant measured inwater but in the presence of a membrane; 
Re, solute/lipid molar ratio; TFP, trifluoperazine; TFP+, charged form; TFP:, neutral form 
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The interaction between phenothiazines and eryth- 
rocyte membranes has been extensively studied. See- 
man [3] described the biphasic effect of TFP on he- 
molysis: at micromolar concentration, it protects 
erythrocytes against hypotonic lysis, whereas at high- 
er concentrations (> 0.1 mM) it produces hemolysis. 
Another phenothiazine, chlorpromazine (CPZ), pro- 
duces small holes in the membrane, suggesting a
colloid-osmotic lytic mechanism [4]. A sublytic 
CPZ concentration also imposes an inward curvature 
on red cell membranes [5], an effect that could be 
attributed to the preferential partition of phenothia- 
zines into the negatively charged cytoplasm leaflet 
of the bilayer [6,7]. Suda et al. [8], using electron 
paramagnetic resonance (EPR), observed that CPZ 
produces an increase in the rotational motion of 
stearic acid spin labels. In a similar way, previous 
results from our laboratory [9] employing EPR 
showed an increased erythrocyte membrane fluidity 
upon TFP addition, accompanied by changes in the 
lipid-protein interactions, as seen by fluorescence. 
EPR studies on erythrocyte ghosts revealed that 
CPZ binds preferentially to ghost proteins rather 
than to lipids [10] and phenothiazines have been re- 
ported to interact specifically with erythrocyte mem- 
brane proteins, such as cytoskeleton protein 4.1 [11], 
aminophospholipid flippase [12] and acetylcholines- 
terase [13]. 
We have previously shown that TFP, an amphi- 
philic molecule whose protonated species form mi- 
celles, is able to protect erythrocytes against mechan- 
ical hemolysis under isosmotic onditions [14] below 
its critical micellar concentration (CMC). Here we 
report further data about TFP-induced hemolysis. 
Incubation of erythrocytes with TFP (above its 
CMC) at pH 7.4 induces mixed micelle formation 
containing both TFP and erythrocyte phospholipids. 
The release of membrane lipids induces the collapse 
of the membrane (unpublished ata). We quantita- 
tively studied TFP and erythrocyte membrane inter- 
action, to determine the effective TFP/lipid ratio for 
membrane activity (protection and lysis). Finally, 
considering that hydrophobic differences between 
charged and uncharged forms of TFP are determi- 
nant factors in TFP membrane interaction and that 
both forms are present at physiologic pH, we ana- 
lyzed the contribution of each TFP species to isos- 
motic hemolysis. 
2. Materials and methods 
TFP hydrochloride (MW 480.4) and egg phospha- 
tidylcholine (EPC) were obtained from Sigma, St 
Louis, MO. 
2.1. Membrane preparation 
Mouse liver microsomes were prepared as de- 
scribed previously [14]. EPC multilamellar vesicles 
were prepared by evaporating stock chloroform 
EPC solutions under a stream of wet nitrogen. The 
samples were left under vacuum for at least 2 h. 
Vesicles were obtained by the addition of phos- 
phate-buffered saline, PBS (5 mM phosphate, pH 
7.4, 150 mM NaCI), and vortexing for 5 min. 
2.2. Erythrocytes 
Freshly obtained mouse blood was collected into 
Alsiver's solution (27 mM sodium citrate/72 mM 
NaCI/ l l4 mM glucose/2.6 mM citric acid) and 
washed three times in PBS. Erythrocyte ghost mem- 
branes were prepared as described by [15]. 
2.3. Protein determination 
Total protein concentration was measured [16] us- 
ing bovine serum albumin as a standard. 
2.4. Phospholipid etermination 
Membrane phospholipid concentration was deter- 
mined according to [17]. 
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2.5. Partition coefficient (P) determination by phase 
separation 
Membranes were prepared as described above and 
kept in PBS. A known amount of TFP was incu- 
bated with the membranes for 10 min at room tem- 
perature. The drug concentration remaining in the 
supernatant after centrifugation at 105000Xg for 
1 h was optically detected at 256 nm (eM = 23 500, 
[18]) against the respective control (membrane in 
PBS). For red blood cells, we used ghosts rather 
than whole erythrocytes because hemoglobin released 
during the experiment overlapped the TFP optical 
spectra, preventing the precise determination of 
TFP in the supernatant. The amount of drug bound 
to the lipid phase was obtained by subtracting the 
supernatant concentration from the total drug con- 
centration measured before phase mixing. The parti- 
tion coefficient, P, was determined according to Eq. 1 
[19]: 
p __ nm(S)/Vm 
nw(s)/Vw (1) 
where: s denotes the solute (TFP), n is the number of 
moles of solute, V= volume and the subscripts m and 
w refer to the membrane and aqueous phase, respec- 
tively. For erythrocytes, ghosts and microsomes, the 
apolar phase volume (Vm) was calculated assuming a
lipid density of 1 g/ml [20,21]. For EPC multilamellar 
vesicles, P was determined after four freeze-thawing 
cycles, increasing the incubation time up to 30 min. 
2.6. Octanol/water P determination 
PBS and n-octanol solutions were pre-equilibrated 
overnight; after TFP addition the mixture was vor- 
texed for 5 min and incubated for 10 min before 
centrifugation at 260 x g for 5 min. P was optically 
determined as described for the phase separation ex- 
periments. 
2. 7. Hemolytic assay under hypotonic onditions 
Erythrocytes (0.14% hematocrit) were incubated in 
hypotonic PBS (5 mM sodium phosphate, pH 7.4, 
66 mM NaC1) that induced 50% hemolysis. TFP in 
the 1-125 I.tM range was added and the samples were 
incubated for 10, 30 and 60 min. After centrifugation 
at 260 ×g for 3 min, released hemoglobin was meas- 
ured in the supernatant at 412 nm. Results are ex- 
pressed on a relative absorbance (RA) scale ranging 
from < 1 (protection against) to > 1 (hemolysis). 
RA= 1 indicates 50% hemolysis obtained for the 
66 mM saline control. The data were analyzed with 
the SAS statistical program [22]. PROC GLM pro- 
grams were used for analysis of variance, with drug 
concentration and incubation time set as independent 
variables and RA as the variable answer. Means 
were compared by Duncan's multiple range test. 
Each RA value represents he mean of 15 independ- 
ent experiments. 
2.8. Isotonic hemolytic assay 
TFP (1-200 ~M) was prepared in isotonic PBS 
solution. Erythrocytes (hematocrits ranging from 
0.04 to 0.14%) were added and the samples kept at 
room temperature (22-25°C) for 10 min. before cen- 
trifugation at 260 × g for 3 min. Hemoglobin released 
into the supernatant was detected at 412 nm (for 
lower hematocrits) and 540 nm (0.14% hematocrit). 
The hemolytic effect, measured as percent relative 
hemolysis (RH), was determined on the basis of re- 
leased hemoglobin, according to the following for- 
mula: 
As-Act 
RH - (2) 
Ac2--Acl 
where A is the absorbance, S the sample, c l the 
mechanical hemolysis control (erythrocytes in PBS), 
and c2 the 100% hemolysis (erythrocytes in water) 
control. 
2.9. Csat, Csol and TFP/lipid ratio (Re) calculation 
Csat (solute concentration needed to start hemoly- 
sis) and Csot (solute concentration for total lysis) [23- 
25] were graphically obtained for each hematocrit 
assayed. Plots of Csat and Csot as a function of lipid 
concentration allowed Re (solute/lipid molar ratio) 
determination for initial (membrane saturation) and 
total hemolysis (solubilization), respectively. Re was 
obtained from the slope of the resulting straight 
lines, as described in Eq. 3 [23-25]: 
Dt = Re[L + l/Kb(Re + 1)] (3) 
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According to these authors, there is a linear rela- 
tionship between the total solute concentration (Dr) 
producing the onset or completion of solubilization 
and the lipid concentration (L) in the system. The y 
intercept corresponds to the concentration of free 
solute, Dw, equivalent to its CMC [23,26]. Kb 
(M -1) describes the solute binding to membranes in
terms of equilibrium: 
[sm] 
s+m~sm Kb--[s][m] 
where s represents he solute and sm the membrane- 
associated species. Binding constants (Kb) and parti- 
tion coefficients (P) are related through the partial 
molar volume, V, of the lipid phase [27,28]. 
Xb = P'V (4) 
For erythrocytes, V was calculated as 0.658 l/mol, 
the average molecular weight of phospholipids, 
sphingolipids and cholesterol, according to the lipid 
composition of erythrocyte membranes described in 
[151. 
2.10. Determination of CMC 
CMC was determined with a K12 Krtiss tensiom- 
eter. We measured the surface tension of TFP solu- 
tions ranging from 0.1 to 100 gM at room temper- 
ature using PBS buffer. 
3. Results and discussion 
Trifluoperazine, a rather soluble piperazine deriv- 
ative (water solubility at pH 7.4 is 1 M according to 
[18]), has an ionizable amine group with a pK of 8.1 
[18] so that, as discussed further in this paper, both 
charged (TFP+) and uncharged (TFP:) forms are 
present at physiologic pH. TFP+ has a CMC of 
42 gM (experimental data determined in PBS, pH 
7.4), indicating that both monomer and aggregate 
forms could be found in the concentration range em- 
ployed here in the hemolytic experiments. 
3.1. TFP partitioning between membranes and water 
Table 1 shows TFP partition coefficients (P) be- 
tween membrane (microsomes, erythrocyte ghosts, 
liposomes) and water and octanol/water systems. 
We can see that TFP partition into the membranes 
was higher than in the isotropic octanol phase and 
depended on membrane composition, so that: 
pmic ~ plip ~ pghost. 
The poct value obtained here is of the same order 
of magnitude as that found for TFP partition be- 
tween hexane/water (PBS, pH 7.4)= 193 [29]. Abso- 
lute P values determined between organic phases (oc- 
tanol) and water were lower than P values between 
membranes and water (Table 1) as also reported by 
other authors [29,30], revealing that P values be- 
tween organic solvents and water are to be used care- 
fully since they provide only poor estimates of the 
relative magnitude of the partition coefficients of the 
drugs in biomembranes [21,31-33]. 
The stronger binding of TFP to microsomes may 
reflect some TFP protein interaction, as the protein 
content of liver microsomes i  higher (ca. 70% of the 
total membrane weight, [34]) than that of ghost 
membranes (55%, [35]). Besides, if we consider the 
fluidity of the ghost membranes we realize that the 
high cholesterol content (30%) of erythrocyte mem- 
branes [36] and the cytoskeleton [9] imposes a rigidity 
that could restrict TFP partition into them, explain- 
ing the rather small pghost value. In fact pghost was 
slightly lower than plip, an unexpected result since 
liposomes lack proteins. It seems that the reduced 
hydrocarbon chain dynamics [36] and increased bi- 
layer bending [37] triggered by cholesterol, added to 
cytoskeleton rigidity, compensate for any TFP/pro- 
tein interaction in ghosts. 
Table 1 
Partition coefficients ~ for TFP between microsomes (pmic), erythrocyte ghosts (eghost), liposomes (plip) octanol (poct) and water (5 mM 
PBS, pH 7.4) 
pmic pghost elip b poet 
7172 + 1229 1380 + 429 1916 + 341 452 + 55 
~Each P value represents the mean + S.E. of nine experiments. Incubation time = 10 min at room temperature. 
bFo r plip we used four freeze-thawing cycles, increasing the incubation time to nearly 30 min. 
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Fig. 1. TFP protection under hypotonic onditions. Hematocrit 
=0.14% in hypotonic (66 mM NaCI) PBS, pH 7.4. Incubation 
time: 10 min at room temperature. 
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Fig. 2. TFP-induced isotonic hemolysis. Hematocrit =0.14% in 
isotonic PBS. Incubation time: 10 min at room temperature. 
Csat and Csol (see text) determination are shown. 
3.2. Studies on TFP induced hemolysis and TFP/lipid 
ratio determination 
Phenothiazine stabilizes erythrocytes against hypo- 
tonic hemolysis at low concentration [3,37]. The bi- 
phasic TFP hemolytic urve under hypotonic ondi- 
tions can be seen in Fig. 1, which shows that TFP at 
concentrations up to 17 /aM protects erythrocytes 
(Ht = 0.14%) against hypotonic lysis, while at higher 
concentrations its action on membranes i lytic (up- 
ward curve). The maximal protective concentration 
of TFP occurs in the 10-17 laM range, i.e. with TFP 
in its monomer form. The data obtained are in agree- 
ment with [3] who reported a maximal TFP protec- 
tive concentration of 10/aM at pH 7.0, with a 0.2% 
hematocrit. Using the maximal protection average 
concentration we calculated the protective TFP/lipid 
ratio (R pr°t) presented in Table 2. 
Experiments like that illustrated in Fig. 1 (10 min 
Table 2 
Effective drug/lipid molar ratios and related parameters in the 
protection and lysis of erythrocytes by trifluoperazine 
Rprot a 0.16 
R sat 0.43 
R~oL 1.45 e 
Dw (~M) b 59 
Kb (M -I)  4783 
~Determined under hyposmotic onditions (Fig. 1). 
bTaken from the saturation curve (Fig. 3). 
incubation) were also performed with TFP pre-incu- 
bated for 30 and 60 min. The results obtained (data 
not shown) presented non-significant differences by 
the Duncan test, indicating that TFP equilibrium be- 
tween the aqueous phase and the erythrocyte mem- 
brane was reached in less than 10 min. 
Fig. 2 shows the hemolytic effect of TFP on eryth- 
rocytes under isotonic condition. No lytic effect was 
observed below 75 ~tM; up to this concentration the 
membrane incorporates TFP without losing its integ- 
rity. Beyond 75 ~tM, lysis increased quickly with TFP 
concentration due to the co-operative ffect of the 
lipid bilayer. Membrane disruption occurs as lipids 
are released to the forming mixed-micelles. 
We used hemolytic urves to obtain Csat and Csol 
values, i.e. TFP concentration for the onset and com- 
plete solubilization of erythrocyte membranes (Fig. 
2). In Fig. 3, we plotted these values as a function 
of lipid concentration (experiments ranging from 
0.15 to 1.5% hematocrit) to obtain the straight lines 
predicted by Eq. 3. The corresponding TFP to lipid 
molar ratio, Re, (Table 2) was readily calculated 
from the saturation and solubilization lines in Fig. 3. 
Theoretically [23], both straight lines in Fig. 3 
should intercept he y axis at Dw, the free TFP con- 
centration in water corresponding to the CMC of the 
amphiphilic molecule in the presence of membranes. 
The Dw values obtained (59 and 94/aM) closely re- 
semble the CMC determined for TFP in water 
(42/aM at pH 7.4). Differences may be due to exper- 
S V.P. Malheiros et al./Biochimiea et Biophysiea Acta 1373 (1998) 332~40 337 
300 
250 
200 
150 
I -  
1 O0 
50 
0 
2'o ,'0 0'o go 1;0 120 
[ LIPID ] pM 
Fig. 3. Effective TFP/lipid molar ratio for membrane saturation 
and solubilization. Csat (o) and Csol (• )  are plotted as a func- 
tion of erythrocyte lipid concentration. Rc values are taken 
from the slope of the straight lines. 
imental errors, since the CMC value is very small, in 
the 10 -5 M range. 
This colloidal behavior of TFP to form micelles 
classifies it as a surface active compound [38]. Its 
CMC is lower than that of surfactants such as Triton 
X-100 (3.7×10 -4 M), SDS (8.3×10 -3 M) or 
CHAPS (3.5 × 10 -3 M) [39,40], an indication of the 
high degree of intermolecular TFP hydrophobic in- 
teractions. In fact, TFP is among the most hydro- 
phobic phenothiazines [29], as also shown in the 
present study by the very low concentration of 
TFP monomers in the water phase (small Dw) at 
pH 7.4. 
Table 2 presents everal parameters derived from 
the biphasic hemolytic experiments. At low TFP con- 
centrations and under hyposmotic onditions a max- 
imum protective ffect was observed at 0.16:1 TFP/ 
lipid molar ratio ( Rpr°t determined from Fig. 1). 
Under isotonic conditions, R TM showed that a ratio 
- -e  
of 0.43:1 TFP/lipid is necessary to reach membrane 
saturation. Higher ratios produced hemolysis, until 
complete membrane solubilization at ca. 1.5:1 TFP/ 
lipid molar ratio sol (R e ). Hemolytic phenomena is 
then a consequence of the erythrocyte membrane 
phospholipids migration to the hydrophobic micelle 
environment. Effective detergent/lipid ratios for 
phospholipid leakage calculated for many other sur- 
face active drugs are in agreement with the values 
observed for TFP. For example, egg phosphatidyl- 
choline bilayers are able to incorporate Triton X-100 
up to 0.71:1 detergent/lipid molar ratios; above 3:1 
molar ratios all phospholipid is converted into mixed 
micelles [24,41]. In phosphatidylcholine v sicles, pal- 
mitoylcarnitine reaches membrane saturation and 
solubilization at 0.8 : 1 and 2:1 molar ratios, respec- 
tively [25]. 
Assuming ideal mixing of lipid and TFP in dilute 
aqueous media [26], the binding constant (Kb) for 
TFP distribution between bilayer and water could 
be obtained from the saturation straight line in Fig. 
3, according to Eq. 5 [23,26]: 
R~"'= Kb'Dw/(l--Kb'Dw) (5) 
The Kb value obtained for TFP between erythro- 
cytes/water was 4.8 × 103 M -1 (Table 2) and, accord- 
ing to Eq. 4, it corresponds to a partition coefficient 
of 7268. Even considering the different methodolo- 
gies employed and the well known variability in P 
values, this rather high partition, comparable to pmic 
(Table 1), cannot be completely explained. It reflects, 
besides TFP hydrophobicity, some non-specific pro- 
tein binding as, in fact, TFP specifically interacts 
with erythrocyte membrane proteins [11-13] and 
with hemoglobin [9], protecting the latter against 
H202 induced oxidation. 
Using this partition coefficient, we can go back to 
RSat and R s°l values in order to determine the real 
e - -c  
TFP/lipid molar ratio inside the membrane. For a 
Ht = 0.15% (7.9 IJg/ml lipid) just 5.4% of the TFP 
would be partitioned in the bilayer (Eq. 1) and the 
molar ratio for saturation and solubilization would 
be 2:100 and 8:100 TFP/lipid, respectively. This 
rather small ratio indicates that hemolysis is not in- 
duced by real saturation of the membrane, but is a 
complex response for both TFP partition into the 
membrane (Csat, Csol increase according to mem- 
brane concentration, Fig. 3), and aggregation (mi- 
celle formation). In this case TFP micellar aggrega- 
tion could play a synergistic effect on the drug- 
membrane interaction, explaining the high partition 
coefficient assigned from Fig. 3. 
3.3. Further investigation of the real TFP 
charged/uncharged ratios Jor the hemolytic effect 
at physiological pH 
In a previous study, we reviewed the effect of dif- 
338 S. V.P. Malheiros et al. / Biochimica et Biophysica Acta 1373 (1998) 332-340 
Table 3 
Partition coefficients for charged and uncharged TFP species 
and ionization constant in water (pK); calculations of ioniza- 
tion constant in the presence of membrane (pKapp) and average 
partition coefficient at pH 7.4 (Paverage) a according to pKapv 
F lip pK d pKapp e Faverage 
TFP+ b TFP: c 
812 2463 8.1 7.62 1432 
aCalculated by the Henderson-Hasselbalch equation, but using 
pKapp (real ionization constant under the assay condition) in- 
stead of pK (see text). 
bDetermined in 20 mM acetate buffer, pH 5.0. 
CDetermined with 20 mM carbonate buffer, at pH 10.5. 
dAccording to [18]. 
eCalculated as in Eq. 6 for a hematocrit =0.15%. 
ferent partitioning of ionizable local anesthetics at 
their ionization constant [28]. It was shown that 
whenever the binding of charged/uncharged forms 
is different it will imply a pK shift of the partitioning 
compound. Tetracaine, for example, has its ioniza- 
tion constant down-shifted from 8.5 to 7.0 in the 
presence of egg PC multilamellar vesicles [42]. 
TFP shows quite different P values for its charged/ 
uncharged forms (Table 3), the neutral form binding 
more strongly (plip : = 2463) than the protonated, less 
hydrophobic species (plip+ =812). According to the 
formalism described by [43], we calculated pKapp, the 
apparent ionization constant in the presence of mem- 
branes, from: 
pKapp = pK--log[(P:'Vm + Vw)/(P+'Vm + Vw)] 
(6) 
An average partition coefficient can be calculated 
as shown by Eq. 8, taking into account the real 
TFP:/TFP+ ratio at pH 7.4 (using pKapp values). 
We call this eaverage (after Lee and Schreier [43], see 
below). 
e+ + (e -z )  (8) 
eaverage -- 1 + Z 
where Z is the [base]/[acid] molar ratio at pH 7.4. 
In fact, Lee and Schreier [43] described a similar 
equation for the calculation of Paverage that also con- 
sider the differences in pK and pKapp. We prefer to 
use Eq. 8 because it permits fast comparison of 
eaverage, corrected or not, by changing the values of 
the [base]/[acid] ratio for pKapp and pK, respectively. 
The calculated values of Paverage obtained from the 
partition coefficients of the charged and uncharged 
TFP forms (measured at pH 5.0 and 10.0, respec- 
tively) between liposomes and water are listed in Ta- 
ble 3. 
For TFP in multilamellar liposomes, the expected 
P value without considering ApK, would be 1086. 
Paverage is 1432, reflecting the contribution of the un- 
charged and charged forms of TFP to its partition at 
pH 7.4, and is in good correlation with the experi- 
mental value (Flip _=. 1916, Table 1). 
eaverage indicates that partitioning is higher than 
one would expect by ignoring the pK shift, so that 
hydrophobic membrane interaction is important for 
the hemolytic effect of trifluoperazine. These results 
explain the direct correlation between the hydropho- 
bicity and biologic effects of phenothiazine com- 
pounds [3,7,29,44]. 
pKapp was found to be 7.62 for TFP in the pres- 
ence of 12 BM lipids (0.15% hematocrit, Table 3), 
revealing a down-shift of ca. 0.5 pH units in the 
presence of membranes. At higher phospholipid con- 
centrations, calculated pKapp was the same. 
Using pKapp in the Henderson-Hasselbalch equa- 
tion (Eq. 7), one can see that the neutral (TFP:) to 
charged (TFP+) molar ratio at pH 7.4 is 1:1.5, in- 
stead of 1:4 as it would be expected if the pK shift 
was neglected. As a consequence, there is no predom- 
inant form of TFP in the hemolytic experiments de- 
scribed before (pH 7.4). 
pH = pK + log[base]/[acid] (7) 
4. Conclusion 
This work quantitatively describes the biphasic 
(protective/inductive) effect of TFP on mouse eryth- 
rocyte hemolysis. TFP protective ffect seems to be 
related to its monomer insertion into the membrane, 
which occurs quickly at concentrations below those 
for membrane saturation (0.43:1, TFP/lipid molar 
ratios). 
Above CMC, trifluoperazine solubilizes mem- 
branes. The results described should be of help in 
the understanding of the molecular mechanisms of 
hemolysis, because TFP acts as a surfactant on the 
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membrane system. Applying classical treatments for 
the interaction of  surface active compounds with lip- 
id vesicles [23] to the hemolytic urves it was possible 
to calculate TFP/l ipid molar  ratios for the onset of  
hemolysis (R sat) and for complete membrane solubi- 
lization sol (R e ). This approach seems to be quite ad- 
equate for the system as Re values keep a good cor- 
relation with those determined for other surfactant 
molecules, and it also permitted the calculation of P 
values from the hemolytic curves, i.e. between whole 
erythrocytes and water. 
Using the calculated partit ion coefficient, we deter- 
mined rather small TFP/l ipid molar  ratios inside the 
membrane for saturation and solubilization what in- 
dicates that hemolysis is not induced by real mem- 
brane saturation, but also by TFP  micelle formation 
that occurs in the concentration range used in the 
hemolytic experiments. 
The amount  of  charged and uncharged TFP  spe- 
cies in the hemolytic experiments was also analyzed 
taking into account the differences between TFP+ 
and TFP:  binding to membranes and its effect on 
the real ionization constant, pKapp [28,42]. Paverage, 
the mean partit ion coefficient at pH 7.4 was esti- 
mated and presented a good agreement with the 
data obtained, eaverage r ceives an important  contri- 
bution of TFP : ,  the uncharged species that is present 
in almost the same proport ion as TFP+ at pH 7.4, 
and which stronger binding is committed to the real 
membrane saturation. 
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